Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1108 | 1044 | 1229 | 1066 | 1357 | 2044 |
Fund Return | 10.78% | 4.43% | 22.89% | 2.16% | 6.3% | 7.41% |
Place in category | 562 | 466 | 323 | 531 | 392 | 86 |
% in Category | 86 | 68 | 48 | 89 | 75 | 33 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Renaissance Global Growth | 4.66B | 12.93 | 6.23 | 10.30 | ||
Renaissance Global Growth Class F | 4.66B | 14.04 | 7.61 | 11.75 | ||
Renaissance International Equity Cl | 1.87B | 11.85 | 3.49 | 8.87 | ||
Renaissance US Equity Income F | 1.48B | 16.57 | 9.50 | 10.75 | ||
Renaissance US Equity Income F Pr | 1.48B | 16.62 | 9.57 | 10.88 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
RBC International Equity Fund D USD | 2.97B | 16.16 | 5.51 | 8.13 | ||
RBC International Equity Sr F | 2.97B | 16.39 | 5.80 | 8.42 | ||
Renaissance International Equity Cl | 1.87B | 11.85 | 3.49 | 8.87 | ||
Manulife World Inv Cl Sr Adv | 1.63B | 15.24 | 3.18 | 6.78 | ||
Manulife World Inv Cl Sr F | 1.63B | 16.42 | 4.58 | 8.22 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 4.61 | 740.3 | -1.63% | |
Taiwan Semiconductor | US8740391003 | 4.39 | 191.56 | -0.72% | |
ASML Holding | NL0010273215 | 3.17 | 619.50 | +0.21% | |
Experian | GB00B19NLV48 | 2.92 | 3,841.0 | +0.24% | |
Keyence | JP3236200006 | 2.88 | 69,070.0 | +1.48% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | BUY |
Summary | Strong Sell | Strong Sell | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review